Actively Recruiting

Phase Not Applicable
Age: 8Years - 18Years
All Genders
NCT05442671

iTONE Trial (exercIse Training in pulmONary hypertEnsion) Exercise Program for Pediatric PH

Led by Children's Hospital of Philadelphia · Updated on 2026-04-22

25

Participants Needed

1

Research Sites

143 weeks

Total Duration

On this page

Sponsors

C

Children's Hospital of Philadelphia

Lead Sponsor

N

National Heart, Lung, and Blood Institute (NHLBI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Children with pulmonary hypertension (PH) engage in less physical activity than their peers. This is a concern since adult data support exercise as a non-pharmacologic treatment for PH. Despite adult data, therapeutic exercise has not been widely adopted in pediatric PH. Investigators have previously demonstrated that children with PH have less skeletal muscle mass in association with worse exercise performance. Interventions to increase physical activity and skeletal muscle mass may improve exercise performance and quality of life in children with PH. This study will use wearable activity monitoring devices to promote physical activity in a 16-week pilot intervention in children and teenager with PH.

CONDITIONS

Official Title

iTONE Trial (exercIse Training in pulmONary hypertEnsion) Exercise Program for Pediatric PH

Who Can Participate

Age: 8Years - 18Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 8-18 years
  • Diagnosed with pulmonary hypertension WHO diagnostic groups 1, 2, 3, or 4
  • WHO functional class I or II
  • Able to walk and move around independently (ambulatory)
  • Mean pulmonary to systemic arterial pressure ratio less than 0.75 if no Potts shunt, or Potts shunt placed at least 6 months before enrollment
  • Stable pulmonary hypertension medication for at least 3 months before the exercise program
  • Access to home Wi-Fi
  • Family has a mobile device capable of receiving text messages
Not Eligible

You will not qualify if you...

  • WHO functional class III or IV
  • Single ventricle heart physiology
  • Moderate to severe kidney disease (greater than stage 3)
  • Severe liver impairment with enzyme levels more than twice the upper limit of normal
  • Currently pregnant
  • Significant developmental delay or inability to follow verbal instructions for study procedures

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, United States, 19104

Actively Recruiting

Loading map...

Research Team

C

Catherine Avitabile, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here